The Effect of Intravitreal Bevacizumab on Central Serous Chorioretinopathy

The aim of this study was to investigate the efficacy of Intravitreal Injection of Bevacizumab (IVB) in patients with Central Serous Chorioretinopathy (CSC) compared to the control group, after four months of injection. In this study, 30 eyes of 30 patients with CSC, who were in the age range of 23...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Med Hypothesis Discov Innov Ophthalmol
Glavni autori: Maleki, Alireza, Nezamdust, Zahra, Salari, Amirmasoud, Ahmadi, Seyed Sajad, Sabbaghi, Hamideh, Bagherzadeh, Omid, Ataollahi, Alireza, Yaseri, Mehdi
Format: Artigo
Jezik:Inglês
Izdano: Medical Hypothesis, Discovery & Innovation Ophthalmology 2018
Teme:
Original Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6229672/
https://ncbi.nlm.nih.gov/pubmed/30505869
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items